SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-22-000017
Filing Date
2022-05-03
Accepted
2022-05-03 16:36:05
Documents
86
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptct-20220331x10q.htm   iXBRL 10-Q 1992512
2 EX-10.1 ptct-20220331ex1014abe02.htm EX-10.1 19084
3 EX-10.2 ptct-20220331ex102aadcc2.htm EX-10.2 203357
4 EX-31.1 ptct-20220331ex311d30849.htm EX-31.1 10918
5 EX-31.2 ptct-20220331ex312b79483.htm EX-31.2 10720
6 EX-32.1 ptct-20220331ex3211112d4.htm EX-32.1 5930
7 EX-32.2 ptct-20220331ex3222a568a.htm EX-32.2 6116
  Complete submission text file 0001070081-22-000017.txt   10918701

Data Files

Seq Description Document Type Size
8 EX-101.SCH ptct-20220331.xsd EX-101.SCH 71004
9 EX-101.CAL ptct-20220331_cal.xml EX-101.CAL 73092
10 EX-101.DEF ptct-20220331_def.xml EX-101.DEF 371014
11 EX-101.LAB ptct-20220331_lab.xml EX-101.LAB 704897
12 EX-101.PRE ptct-20220331_pre.xml EX-101.PRE 572567
80 EXTRACTED XBRL INSTANCE DOCUMENT ptct-20220331x10q_htm.xml XML 2125161
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 22887603
SIC: 2834 Pharmaceutical Preparations